catalyst

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 — primary completion

as of 2026-07-01
Monitor thisAsk about this
at a glance
2014-09 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.

Event

What
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 — primary completion
Type
Trial Readout
Date
2014-09
Date type
ACTUAL
Phase
Phase 3
This event happened.
relationships
The graph out of here
trial
Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment
trial